Ftse Mib
34.228,77
0,71%
DAX
18.430,05
1,42%
S&P 500
5.185,48
0,09%
NASDAQ
16.378,14
0,18%
Bitcoin
63.373,39
0,32%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ProKidney Corporation (PROK) ProKidney Corporation (PROK) Notizie

ProKidney Corporation

PROK
2,345
0,105 (4,69%)
Ultimo aggiornamento: 19:39:13
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 8-K - Current report
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202422:19EDGAR2Form 8-K - Current report
19/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
05/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202312:58EDGAR2Form 8-K - Current report
22/11/202315:22EDGAR2Form S-3 - Registration statement under Securities Act of..
20/11/202312:11EDGAR2Form 8-K - Current report
14/11/202312:09EDGAR2Form 8-K - Current report
13/11/202323:28EDGAR2Form 8-K - Current report
30/10/202321:12GLOBEProKidney Announces Four Abstracts Selected for Presentation..
11/9/202314:01EDGAR2Form 8-K - Current report
05/9/202312:05GLOBEProKidney to Participate in Fireside Chat at the Morgan..
30/8/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:07EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202315:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202322:33EDGAR2Form 8-K - Current report
10/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10GLOBEProKidney Reports Second Quarter Financial Results and..
03/8/202314:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/7/202322:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/7/202314:01EDGAR2Form 8-K - Current report
18/7/202312:05GLOBEProKidney Announces Closing of Purchase of Manufacturing..
17/7/202312:05GLOBEProKidney Appoints Bruce Culleton, MD, as Executive Vice..
06/7/202322:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:06EDGAR2Form 8-K - Current report
13/6/202318:05GLOBEProKidney Announces Purchase of Manufacturing Facility in..
01/6/202322:05GLOBEProKidney to Participate in Fireside Chat at the Jefferies..
11/5/202322:01GLOBEProKidney Reports First Quarter Financial Results and Recent..
Apertura: 2,24 Min: 2,1903 Max: 2,3993
Chiusura: 2,24

La tua Cronologia

NASDAQ
PROK
ProKidney
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network